5-alpha reductase inhibitor API in powder form used by generic drug manufacturers for oral tablet production targeting androgenetic alopecia and benign prostatic hyperplasia treatments. Distributed to compounding pharmacies and exported to global pharmaceutical markets for endocrine disorder management.